List of Studies ( Metabolite:4-Pyridone)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST001062 | AN001736 | Arabidopsis Nit1 knockout metabolomics | Plant | Arabidopsis thaliana | University of California, Davis | Arbitrary units | |
| ST001432 | AN002394 | A Compromised Developmental Trajectory of the Infant Gut Microbiome and Metabolome in Atopic Eczema - (untargeted global metabolomics profiling) ) | Feces | Human | Eczema | National University of Singapore (NUS) | Ion Count Per Second |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Blood | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
| ST002132 | AN003487 | Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data | Liver | Baboon | Wake Forest School of Medicine | Normalized Peak abundances | |
| ST000164 | AN000256 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Bone marrow | Mouse | Diabetes | New York University | Peak area |
| ST000164 | AN000257 | Metabolomic analysis of normal and diabetic mouse bone marrow under PBS or metformin treatment | Bone marrow | Mouse | Diabetes | New York University | Peak area |
| ST000586 | AN000901 | Evaluation of specific concentrations for use in experimental protocol | Blood | Human | Duke University | Peak area (Log2 transformed) | |
| ST000589 | AN000904 | Effects of dilution on analyte identification and quantification | Blood | Human | Duke University | Peak area (Log2 transformed) | |
| ST001937 | AN003150 | Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules | Blood | Human | Cancer | China Pharmaceutical University | peak height |
| ST000978 | AN001602 | Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir Cohort. | Blood | Human | Kidney disease | Sao Paulo University | Peak height |
| ST000418 | AN000660 | The role of CFTR in the regulation of intrinsic defense mechanisms of exocrine secretions | Saliva | Human | Cystic fibrosis | RTI International | Peak intensity |
| ST000421 | AN000663 | ms3076 T1D poor glycemic control and control samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000667 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000422 | AN000669 | Type 1 Diabetes good glycemic control and controls samples | Blood | Human | Diabetes | Mayo Clinic | Peak intensity |
| ST000893 | AN001455 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Metabolism In Vivo | Muscle | Mouse | Cancer | University of North Carolina | Peak values (Log transformed) |
| ST000895 | AN001457 | Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis | Blood | Mouse | Cancer | University of North Carolina | Peak values (Log transformed) |
| ST000925 | AN001518 | MuRF1-Related Metabolomic Changes in Stretched and Unloaded HL-1 Cells | Cardiomyocyte cells | Mouse | University of North Carolina | Peak values (Log transformed) | |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Intestine | Pig | Sepsis | Indiana University School of Medicine | Peak values (Log transformed) |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Liver | Pig | Sepsis | Indiana University School of Medicine | Peak values (Log transformed) |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Lung | Pig | Sepsis | Indiana University School of Medicine | Peak values (Log transformed) |
| ST001190 | AN001982 | Sepsis-related metabolic changes in ileum, jejunum, skeletal muscle, liver and lung | Muscle | Pig | Sepsis | Indiana University School of Medicine | Peak values (Log transformed) |
| ST000046 | AN000076 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000077 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000046 | AN000079 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000081 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
